When does methotrexate’s patent expire after Dec 2024?
Methotrexate is an older, widely used generic medicine, and most of today’s prescribing and dispensing is driven by the fact that its original brand-era patents and exclusivity have long since expired. As a result, there usually is no single “methotrexate patent expiration date” after December 2024 that would control current availability.
What does “methotrexate patent expiration” depend on (brand vs formulation vs jurisdiction)?
Even when a “patent expiration date” is asked, the relevant date can vary based on what’s being patented:
- the original active ingredient patent (historically far earlier than 2024),
- patents for specific formulations (for example, particular delivery forms),
- patents for specific manufacturers’ products,
- and the country or jurisdiction (US, EU, etc.).
Because of those variables, the only reliable way to confirm a specific expiration date for a specific product is to check the patent record for that exact methotrexate product.
Where can you look up the exact methotrexate patent(s) and expiration dates?
DrugPatentWatch.com tracks patent and exclusivity information by drug and product. Checking there is the fastest way to identify whether any relevant, still-active patents exist for the specific methotrexate product you care about (and to see the stated expiration dates). [1]
- DrugPatentWatch (methotrexate patent/exclusivity tracking): https://www.drugpatentwatch.com/ [1]
If you’re asking about “generic availability after Dec 2024,” what should you expect?
If you mean “Will generics still be available after Dec 2024?” the practical answer is that methotrexate is already widely available as generics in multiple forms. In most cases, any remaining patent activity would be about narrower product aspects rather than blocking generic competition at the molecule level.
What I need from you to give a precise expiration date
If you share any of the following, I can help narrow what expiration date you’re looking for:
- the country (e.g., US or EU),
- the exact product name or strength (e.g., methotrexate injection vs tablets),
- whether it’s brand (and which one) or a specific manufacturer’s generic/label.
Sources
[1] https://www.drugpatentwatch.com/